Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Analysts See 78% Upside Potential 29 September 2025
BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Unveiling a 77.69% Potential Upside 22 September 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking a 69% Potential Upside 8 September 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unraveling a 67.52% Potential Upside for Investors 1 September 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unlocking 66% Upside Potential Amidst Strong Revenue Growth 25 August 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 69% Upside Potential Beckons Investors 11 August 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 65% Upside Potential with Strong Buy Ratings 4 August 2025
BioMarin Pharmaceutical Inc. (BMRN): Analyst Ratings Suggest a Robust 63.12% Upside – What Investors Need to Know 28 July 2025
BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Analyzing the 67% Potential Upside 21 July 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Potential Upside of 64.89% Awaits Investors 14 July 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 66% Upside Potential Amid Strong Analyst Ratings 7 July 2025
BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Analyzing a Biotech Leader with 74% Upside Potential 23 June 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 70% Upside Potential Sparks Investor Interest 16 June 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring the 65.16% Potential Upside for Investors 2 June 2025
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unlocking a 66.65% Potential Upside in the Biotech Sector 26 May 2025
Oriole Resources: Strong Grades and Growing Confidence at MB01 North in Cameroon (Video) 27 January 2026
The Diverse Income Trust: Why Gervais Williams Is Doubling Down on Overlooked UK Small Caps (video) 27 January 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
Gervais Williams backs Ithaca Energy for sustained returns and exceptional dividend potential (LON:ITH) 9 February 2026
Plus500 reports FY 2025 results with strategic expansion and strong shareholder returns 9 February 2026
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential 2 June 2025
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
